Print

The CONSORT Statement is an evidence-based, minimum set of recommendations for reporting RCTs. It offers a standard way to prepare reports of trial findings, facilitating their complete and transparent reporting, and aiding their critical appraisal and interpretation. 

 

The standard CONSORT statement focuses on trials in which individual participants are randomly assigned to study groups. This extension of the CONSORT statement concerns situations where it is preferable to randomly assign groups (such as patients clustered in medical practices).

 

Another extension of the CONSORT statement intended to improve the reporting of noninferiority and equivalence trials - the article explains the rationale for such trials and provides illustrative examples of good reporting practice.

 

This extension of the CONSORT statement is intended to improve the reporting of pragmatic trials - broadly defined as a randomised controlled trial whose purpose is to inform decisions about practice.

 

The CONSORT-PRO extention is intende to give guidance on the reporting of patient-reported outcomes (PROs) as proposed by the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network.

 

The STROBE statement stands for an international, collaborative initiative of specialist involved in STrengthening the Reporting of OBservational studies in Epidemiology.

 

The STREGA recommendations (STrengthening the REporting of Genetic Association studies) provides additions to 12 of the 22 items of the STROBE statement.

 

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions is an update and expansion of the QUOROM statement published in 1999. See the PRISMA checklist and flow diagram.